The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Xeris Pharmaceuticals, Inc(NASDAQ:XERS)


Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technology platforms allow for the subcutaneous and intramuscular delivery of highly-concentrated, re...
Website: http://www.xerispharma.com
Founded: 2005
Full Time Employees: 172
Sector: Healthcare
Industry: Biotechnology
Xeris Pharmaceuticals Days Payable Outstanding ttm (DPO)
Xeris Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Xeris Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Xeris Pharmaceuticals Op Cashflow Per Share ttm
Xeris Pharmaceuticals Free Cashflow Per Share ttm
Xeris Pharmaceuticals Cash Per Share ttm
Xeris Pharmaceuticals P/S ratio ttm
Xeris Pharmaceuticals (GAAP) P/E ratio ttm
Xeris Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.